Loading Blender model...
Quality
metformin (blue N atoms, to liver)
inositol ring (red O atoms, to ovary)
glow = insulin-resistance load
Drag to orbit, wheel / pinch to zoom

Metformin vs Inositol 3D: Liver-Ovary Pharmacokinetics

Blender 5.2 model, Three.js r160. Orbit to see the organs at real relative depth.
Educational model only, not medical advice. It cannot say which treatment anyone should take; real responses vary. Ask a clinician.
HOMA-IR
Androgen index
Ovulations / year
GI side effects
Plasma metformin
Plasma inositol
The science

PK (one compartment, oral, twice daily):

C(t) = F·D·ka / (V·(ka−ke)) · (e^(−ke t) − e^(−ka t))
C_ss,avg = F·D / (CL·τ),  CL = ke·V,  τ = 12 h

PD (Emax + indirect response): E = Emax·C/(EC50 + C); HOMA-IR relaxes to R0·(1−E) with rate kout (half-life about 3 weeks). Two drugs combine by Bliss independence, E12 = 1−(1−E1)(1−E2): no synergy is assumed.

Androgen / ovulation: androgen index = 1 − 0.6·(1 − R/R0); ovulation probability per 28-day cycle = clamp(0.30 + 1.1·(1 − index), 0.30, 0.75). Illustrative maps, not fitted.

Simplifications: round-number parameters inside published ranges; one typical adult; no kidney function, no extended-release forms, no diet or weight change, no inter-person variation. Metformin (mainly hepatic) and inositol (second-messenger precursor) are both collapsed into one effect on insulin resistance. Head-to-head trials are small and mixed; the model does not show that either drug wins. The 3D organs are schematic, not anatomical scans.

Numerical checks
Open the 2D version
Made with 🟠 Blender · Three.js